Pilot Study of Natural Killer Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis. (Q50982454)

26 March 2018

title

Pilot Study of Natural Killer Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis. (English)

1 reference

26 March 2018

main subject

multiple sclerosis

0 references

author

Sonya Marshall-Gradisnik

7

object named as

S Marshall-Gradisnik

1 reference

26 March 2018

Don Staines

6

object named as

D Staines

1 reference

26 March 2018

author name string

T K Huth

1

1 reference

26 March 2018

E W Brenu

2

1 reference

26 March 2018

S Ramos

3

1 reference

26 March 2018

T Nguyen

4

1 reference

26 March 2018

S Broadley

5

1 reference

26 March 2018

publication date

18 September 2015

1 reference

26 March 2018

Scandinavian Journal of Immunology

published in

1 reference

26 March 2018

volume

83

1 reference

26 March 2018

issue

1

1 reference

26 March 2018

page(s)

44-51

1 reference

26 March 2018

Myalgic encephalomyelitis: International Consensus Criteria

cites work

1 reference

Chronic fatigue syndrome, the immune system and viral infection

21 January 2018

1 reference

Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics

21 January 2018

1 reference

Measuring fatigue in patients with multiple sclerosis: reproducibility, responsiveness and concurrent validity of three Dutch self-report questionnaires.

21 January 2018

1 reference

Immunological aspects of chronic fatigue syndrome

21 January 2018

1 reference

Gender differences in multiple sclerosis: induction of estrogen signaling in male and progesterone signaling in female lesions.

21 January 2018

1 reference

Sex and gender issues in multiple sclerosis

21 January 2018

1 reference

Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis.

21 January 2018

1 reference

Human natural killer cells

21 January 2018

1 reference

Up on the tightrope: natural killer cell activation and inhibition

21 January 2018

1 reference

Activation of NK cell cytotoxicity

21 January 2018

1 reference

Granzymes: a family of lymphocyte granule serine proteases

21 January 2018

1 reference

Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.

21 January 2018

1 reference

CD56bright natural killer (NK) cells: an important NK cell subset.

21 January 2018

1 reference

Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells

21 January 2018

1 reference

Natural killer type 2 bias in remission of multiple sclerosis

21 January 2018

1 reference

Analysis of the cellular mechanism underlying inhibition of EAE after treatment with anti-NKG2A F(ab')2

21 January 2018

1 reference

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

21 January 2018

1 reference

Coagulation status and biochemical and inflammatory markers in multiple sclerosis

21 January 2018

1 reference

KIR2DL5: An Orphan Inhibitory Receptor Displaying Complex Patterns of Polymorphism and Expression.

21 January 2018

1 reference

Altered natural killer cells' response to herpes virus infection in multiple sclerosis involves KIR2DL2 expression.

21 January 2018

1 reference

Human natural killer cells: Molecular mechanisms controlling NK cell activation and tumor cell lysis

21 January 2018

1 reference

Increased expression of non-functional killer inhibitory receptor CD94 in CD8+ cells of myeloma patients.

21 January 2018

1 reference

Synergistic inhibition of natural killer cells by the nonsignaling molecule CD94.

21 January 2018

1 reference

KIR: diverse, rapidly evolving receptors of innate and adaptive immunity

21 January 2018

1 reference

Evaluation of the implication of KIR2DL2 receptor in multiple sclerosis and herpesvirus susceptibility

21 January 2018

1 reference

Glatiramer acetate attenuates the pro-migratory profile of adhesion molecules on various immune cell subsets in multiple sclerosis.

21 January 2018

1 reference

The role of adhesion molecules in multiple sclerosis: biology, pathogenesis and therapeutic implications

21 January 2018

1 reference

The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression

21 January 2018

1 reference

Comparison of primary human cytotoxic T-cell and natural killer cell responses reveal similar molecular requirements for lytic granule exocytosis but differences in cytokine production

21 January 2018

1 reference

Epigenetic modification and antibody-dependent expansion of memory-like NK cells in human cytomegalovirus-infected individuals

21 January 2018

1 reference

Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function

21 January 2018

1 reference

Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells

21 January 2018

1 reference

CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset.

21 January 2018

1 reference

Differential activation of CD57-defined natural killer cell subsets during recall responses to vaccine antigens

21 January 2018

1 reference

KIRs and their HLA ligands in Remitting–Relapsing Multiple Sclerosis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/SJI.12388

1 reference

26 March 2018

PubMed ID

26381393

1 reference

26 March 2018